Predicting relapse risk in childhood acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 162, Issue 5, 2013, Pages 606-620

  Teachey, David T ^a   Hunger, Stephen P ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Acute leukaemia; Acute lymphoblastic leukaemia; Childhood haematological malignancies; Cytogenetics of leukaemia; Minimal residual disease

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; DASATINIB; IMATINIB; MIXED LINEAGE LEUKEMIA PROTEIN; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; BCR ABL1 ONCOGENE; CANCER PROGNOSIS; CANCER RESISTANCE; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHILDHOOD LEUKEMIA; CHROMOSOME 21; CHROMOSOME TRANSLOCATION; ETV6 RUNX1 GENE; EVENT FREE SURVIVAL; FLOW CYTOMETRY; FUSION GENE; GENE FUSION; GENE TRANSLOCATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HIGH THROUGHPUT SEQUENCING; IMMUNOPHENOTYPING; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MINIMAL RESIDUAL DISEASE; MLL GENE; MOLECULARLY TARGETED THERAPY; ONCOGENE; OVERALL SURVIVAL; PHARMACOGENOMICS; PHILADELPHIA 1 CHROMOSOME; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TCF3 HLF GENE; TCF3 PBX1 GENE;

ACUTE LEUKAEMIA; ACUTE LYMPHOBLASTIC LEUKAEMIA; CHILDHOOD HAEMATOLOGICAL MALIGNANCIES; CYTOGENETICS OF LEUKAEMIA; MINIMAL RESIDUAL DISEASE;

CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; HUMANS; INFANT; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84881669095     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12442     Document Type: Review

References (110)

1. Arico, M., Valsecchi, M.G., Camitta, B., Schrappe, M., Chessells, J., Baruchel, A., Gaynon, P., Silverman, L., Janka-Schaub, G., Kamps, W., Pui, C.H. & Masera, G. (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. The New England Journal of Medicine, 342, 998-1006.
2. Arico, M., Schrappe, M., Hunger, S.P., Carroll, W.L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., Horibe, K., Benoit, Y., Pieters, R., Escherich, G., Silverman, L.B., Pui, C.H. & Valsecchi, M.G. (2010) Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 28, 4755-4761.
3. Attarbaschi, A., Mann, G., Panzer-Grumayer, R., Rottgers, S., Steiner, M., Konig, M., Csinady, E., Dworzak, M.N., Seidel, M., Janousek, D., Moricke, A., Reichelt, C., Harbott, J., Schrappe, M., Gadner, H. & Haas, O.A. (2008) Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26, 3046-3050.
4. Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. & van't Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, 1783-1786.
5. Biondi, A., Schrappe, M., De Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Li, C.K., Vora, A., Arico, M., Rottgers, S., Saha, V. & Valsecchi, M.G. (2012) Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. The Lancet Oncology, 13, 936-945.
6. Borowitz, M.J., Devidas, M., Hunger, S.P., Bowman, W.P., Carroll, A.J., Carroll, W.L., Linda, S., Martin, P.L., Pullen, D.J., Viswanatha, D., Willman, C.L., Winick, N. & Camitta, B.M. (2008) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood, 111, 5477-5485.
7. Bruggemann, M., Schrauder, A., Raff, T., Pfeifer, H., Dworzak, M., Ottmann, O.G., Asnafi, V., Baruchel, A., Bassan, R., Benoit, Y., Biondi, A., Cave, H., Dombret, H., Fielding, A.K., Foa, R., Gokbuget, N., Goldstone, A.H., Goulden, N., Henze, G., Hoelzer, D., Janka-Schaub, G.E., Macintyre, E.A., Pieters, R., Rambaldi, A., Ribera, J.M., Schmiegelow, K., Spinelli, O., Stary, J., von Stackelberg, A., Kneba, M., Schrappe, M. & van Dongen, J.J. (2010) Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia, 24, 521-535.
8. Bruggemann, M., Gokbuget, N. & Kneba, M. (2012) Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle. Seminars in oncology, 39, 47-57.
9. Campana, D. (2012) Minimal residual disease monitoring in childhood acute lymphoblastic leukemia. Current opinion in hematology, 19, 313-318.
10. Campos-Sanchez, E., Toboso-Navasa, A., Romero-Camarero, I., Barajas-Diego, M., Sanchez-Garcia, I. & Cobaleda, C. (2011) Acute lymphoblastic leukemia and developmental biology: a crucial interrelationship. Cell Cycle, 10, 3473-3486.
11. Chang, B.H., Willis, S.G., Stork, L., Hunger, S.P., Carroll, W.L., Camitta, B.M., Winick, N.J., Druker, B.J. & Schultz, K.R. (2012) Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ ALL: a Children's Oncology Group (COG) study. British journal of haematology, 157, 507-510.
12. Cleaver, A.L., Beesley, A.H., Firth, M.J., Sturges, N.C., O'Leary, R.A., Hunger, S.P., Baker, D.L. & Kees, U.R. (2010) Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study. Molecular Cancer, 9, 105.
13. Cloppenborg, T., Stanulla, M., Zimmermann, M., Schrappe, M., Welte, K. & Klein, C. (2005) Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups. Leukemia, 19, 44-48.
14. Conter, V., Arico, M., Basso, G., Biondi, A., Barisone, E., Messina, C., Parasole, R., De Rossi, G., Locatelli, F., Pession, A., Santoro, N., Micalizzi, C., Citterio, M., Rizzari, C., Silvestri, D., Rondelli, R., Lo Nigro, L., Ziino, O., Testi, A.M., Masera, G. & Valsecchi, M.G. (2010a) Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia, 24, 255-264.
15. Conter, V., Bartram, C.R., Valsecchi, M.G., Schrauder, A., Panzer-Grumayer, R., Moricke, A., Arico, M., Zimmermann, M., Mann, G., De Rossi, G., Stanulla, M., Locatelli, F., Basso, G., Niggli, F., Barisone, E., Henze, G., Ludwig, W.D., Haas, O.A., Cazzaniga, G., Koehler, R., Silvestri, D., Bradtke, J., Parasole, R., Beier, R., van Dongen, J.J., Biondi, A. & Schrappe, M. (2010b) Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood, 115, 3206-3214.
16. Coustan-Smith, E., Behm, F.G., Sanchez, J., Boyett, J.M., Hancock, M.L., Raimondi, S.C., Rubnitz, J.E., Rivera, G.K., Sandlund, J.T., Pui, C.H. & Campana, D. (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet, 351, 550-554.
17. Coustan-Smith, E., Mullighan, C.G., Onciu, M., Behm, F.G., Raimondi, S.C., Pei, D., Cheng, C., Su, X., Rubnitz, J.E., Basso, G., Biondi, A., Pui, C.H., Downing, J.R. & Campana, D. (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. The Lancet Oncology, 10, 147-156.
18. Den Boer, M.L., van Slegtenhorst, M., De Menezes, R.X., Cheok, M.H., Buijs-Gladdines, J.G., Peters, S.T., Van Zutven, L.J., Beverloo, H.B., Van der Spek, P.J., Escherich, G., Horstmann, M.A., Janka-Schaub, G.E., Kamps, W.A., Evans, W.E. & Pieters, R. (2009) A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. The Lancet Oncology, 10, 125-134.
19. Einsiedel, H.G., von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hahlen, K., Gobel, U., Klingebiel, T., Ludwig, W.D. & Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 23, 7942-7950.
20. Emerenciano, M., Meyer, C., Mansur, M.B., Marschalek, R. & Pombo-de-Oliveira, M.S. (2013) The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia. British journal of haematology, 161, 224-236.
21. Faham, M., Zheng, J., Moorhead, M., Carlton, V.E., Stow, P., Coustan-Smith, E., Pui, C.H. & Campana, D. (2012) Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood, 120, 5173-5180.
22. Franca, R., Rebora, P., Basso, G., Biondi, A., Cazzaniga, G., Crovella, S., Decorti, G., Fagioli, F., Giarin, E., Locatelli, F., Poggi, V., Valsecchi, M.G. & Rabusin, M. (2012) Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. Pharmacogenomics, 13, 1905-1916.
23. van Galen, J.C., Kuiper, R.P., van Emst, L., Levers, M., Tijchon, E., Scheijen, B., Waanders, E., van Reijmersdal, S.V., Gilissen, C., van Kessel, A.G., Hoogerbrugge, P.M. & van Leeuwen, F.N. (2010) BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. Blood, 115, 4810-4819.
24. Gaynon, P.S., Angiolillo, A.L., Carroll, W.L., Nachman, J.B., Trigg, M.E., Sather, H.N., Hunger, S.P. & Devidas, M. (2010) Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia, 24, 285-297.
25. Ginsburg, G.S. (2013) Realizing the opportunities of genomics in health care. JAMA: the journal of the American Medical Association, 309, 1463-1464.
26. Greaves, M. & Maley, C.C. (2012) Clonal evolution in cancer. Nature, 481, 306-313.
27. Gutierrez, A., Dahlberg, S.E., Neuberg, D.S., Zhang, J., Grebliunaite, R., Sanda, T., Protopopov, A., Tosello, V., Kutok, J., Larson, R.S., Borowitz, M.J., Loh, M.L., Ferrando, A.A., Winter, S.S., Mullighan, C.G., Silverman, L.B., Chin, L., Hunger, S.P., Sallan, S.E. & Look, A.T. (2010) Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 28, 3816-3823.
28. Harrison, C.J., Moorman, A.V., Broadfield, Z.J., Cheung, K.L., Harris, R.L., Reza Jalali, G., Robinson, H.M., Barber, K.E., Richards, S.M., Mitchell, C.D., Eden, T.O., Hann, I.M., Hill, F.G., Kinsey, S.E., Gibson, B.E., Lilleyman, J., Vora, A., Goldstone, A.H., Franklin, I.M., Durrant, J. & Martineau, M. (2004) Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. British journal of haematology, 125, 552-559.
29. Harrison, C.J., Haas, O., Harbott, J., Biondi, A., Stanulla, M., Trka, J. & Izraeli, S. (2010) Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group. British journal of haematology, 151, 132-142.
30. Harvey, R.C., Mullighan, C.G., Wang, X., Dobbin, K.K., Davidson, G.S., Bedrick, E.J., Chen, I.M., Atlas, S.R., Kang, H., Ar, K., Wilson, C.S., Wharton, W., Murphy, M., Devidas, M., Carroll, A.J., Borowitz, M.J., Bowman, W.P., Downing, J.R., Relling, M., Yang, J., Bhojwani, D., Carroll, W.L., Camitta, B., Reaman, G.H., Smith, M., Hunger, S.P. & Willman, C.L. (2010a) Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood, 116, 4874-4884.
31. Harvey, R.C., Mullighan, C.G., Chen, I.M., Wharton, W., Mikhail, F.M., Carroll, A.J., Kang, H., Liu, W., Dobbin, K.K., Smith, M.A., Carroll, W.L., Devidas, M., Bowman, W.P., Camitta, B.M., Reaman, G.H., Hunger, S.P., Downing, J.R. & Willman, C.L. (2010b) Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood, 115, 5312-5321.
32. Hertzberg, L., Vendramini, E., Ganmore, I., Cazzaniga, G., Schmitz, M., Chalker, J., Shiloh, R., Iacobucci, I., Shochat, C., Zeligson, S., Cario, G., Stanulla, M., Strehl, S., Russell, L.J., Harrison, C.J., Bornhauser, B., Yoda, A., Rechavi, G., Bercovich, D., Borkhardt, A., Kempski, H., te Kronnie, G., Bourquin, J.P., Domany, E. & Izraeli, S. (2010) Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood, 115, 1006-1017.
33. Hogan, L.E., Meyer, J.A., Yang, J., Wang, J., Wong, N., Yang, W., Condos, G., Hunger, S.P., Raetz, E., Saffery, R., Relling, M.V., Bhojwani, D., Morrison, D.J. & Carroll, W.L. (2011) Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood, 118, 5218-5226.
34. Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M., Andersson, A., Chen, S.C., McCastlain, K., Becksfort, J., Ma, J., Wu, G., Patel, S.N., Heatley, S.L., Phillips, L.A., Song, G., Easton, J., Parker, M., Chen, X., Rusch, M., Boggs, K., Vadodaria, B., Hedlund, E., Drenberg, C., Baker, S., Pei, D., Cheng, C., Huether, R., Lu, C., Fulton, R.S., Fulton, L.L., Tabib, Y., Dooling, D.J., Ochoa, K., Minden, M., Lewis, I.D., To, L.B., Marlton, P., Roberts, A.W., Raca, G., Stock, W., Neale, G., Drexler, H.G., Dickins, R.A., Ellison, D.W., Shurtleff, S.A., Pui, C.H., Ribeiro, R.C., Devidas, M., Carroll, A.J., Heerema, N.A., Wood, B., Borowitz, M.J., Gastier-Foster, J.M., Raimondi, S.C., Mardis, E.R., Wilson, R.K., Downing, J.R., Hunger, S.P., Loh, M.L. & Mullighan, C.G. (2013) The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nature genetics, 45, 242-252.
35. Hu, Y., Liu, Y., Pelletier, S., Buchdunger, E., Warmuth, M., Fabbro, D., Hallek, M., Van Etten, R.A. & Li, S. (2004) Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nature genetics, 36, 453-461.
36. Hunger, S.P. (1996) Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood, 87, 1211-1224.
37. Hunger, S.P. (2011) Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2011, 361-365.
38. Hunger, S.P., Fall, M.Z., Camitta, B.M., Carroll, A.J., Link, M.P., Lauer, S.J., Mahoney, D.H., Pullen, D.J., Shuster, J.J., Steuber, C.P. & Cleary, M.L. (1998) E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood, 91, 1021-1028.
39. Hunger, S.P., Raetz, E.A., Loh, M.L. & Mullighan, C.G. (2011) Improving outcomes for high-risk ALL: translating new discoveries into clinical care. Pediatric blood & cancer, 56, 984-993.
40. Hunger, S.P., Lu, X., Devidas, M., Camitta, B.M., Gaynon, P.S., Winick, N.J., Reaman, G.H. & Carroll, W.L. (2012) Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30, 1663-1669.
41. Jeha, S., Pei, D., Raimondi, S.C., Onciu, M., Campana, D., Cheng, C., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Howard, S.C., Downing, J.R., Evans, W.E., Relling, M.V. & Pui, C.H. (2009) Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia, 23, 1406-1409.
42. Kadan-Lottick, N.S., Ness, K.K., Bhatia, S. & Gurney, J.G. (2003) Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA: The Journal of the American Medical Association, 290, 2008-2014.
43. Kamps, W.A., van der Pal-de Bruin, K.M., Veerman, A.J., Fiocco, M., Bierings, M. & Pieters, R. (2010) Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia, 24, 309-319.
44. Kang, H., Wilson, C.S., Harvey, R.C., Chen, I.M., Murphy, M.H., Atlas, S.R., Bedrick, E.J., Devidas, M., Carroll, A.J., Robinson, B.W., Stam, R.W., Valsecchi, M.G., Pieters, R., Heerema, N.A., Hilden, J.M., Felix, C.A., Reaman, G.H., Camitta, B., Winick, N., Carroll, W.L., Dreyer, Z.E., Hunger, S.P. & Willman, C.L. (2012) Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood, 119, 1872-1881.
45. Kerst, G., Kreyenberg, H., Roth, C., Well, C., Dietz, K., Coustan-Smith, E., Campana, D., Koscielniak, E., Niemeyer, C., Schlegel, P.G., Muller, I., Niethammer, D. & Bader, P. (2005) Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR. British journal of haematology, 128, 774-782.
46. Krivtsov, A.V. & Armstrong, S.A. (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nature reviews. Cancer, 7, 823-833.
47. Kuster, L., Grausenburger, R., Fuka, G., Kaindl, U., Krapf, G., Inthal, A., Mann, G., Kauer, M., Rainer, J., Kofler, R., Hall, A., Metzler, M., Meyer, L.H., Meyer, C., Harbott, J., Marschalek, R., Strehl, S., Haas, O.A. & Panzer-Grumayer, R. (2011) ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling. Blood, 117, 2658-2667.
48. Lauten, M., Moricke, A., Beier, R., Zimmermann, M., Stanulla, M., Meissner, B., Odenwald, E., Attarbaschi, A., Niemeyer, C., Niggli, F., Riehm, H. & Schrappe, M. (2012) Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica, 97, 1048-1056.
49. Loh, M.L., Goldwasser, M.A., Silverman, L.B., Poon, W.M., Vattikuti, S., Cardoso, A., Neuberg, D.S., Shannon, K.M., Sallan, S.E. & Gilliland, D.G. (2006) Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01. Blood, 107, 4508-4513.
50. Loh, M.L., Zhang, J., Harvey, R.C., Roberts, K., Payne-Turner, D., Kang, H., Wu, G., Chen, X., Becksfort, J., Edmonson, M., Buetow, K.H., Carroll, W.L., Chen, I.M., Wood, B., Borowitz, M.J., Devidas, M., Gerhard, D.S., Bowman, P., Larsen, E., Winick, N., Raetz, E., Smith, M., Downing, J.R., Willman, C.L., Mullighan, C.G. & Hunger, S.P. (2013) Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. Blood, 121, 485-488.
51. Maloney, K.W. (2011) Acute lymphoblastic leukaemia in children with Down syndrome: an updated review. British journal of haematology, 155, 420-425.
52. Meyer, J.A., Wang, J., Hogan, L.E., Yang, J.J., Dandekar, S., Patel, J.P., Tang, Z., Zumbo, P., Li, S., Zavadil, J., Levine, R.L., Cardozo, T., Hunger, S.P., Raetz, E.A., Evans, W.E., Morrison, D.J., Mason, C.E. & Carroll, W.L. (2013) Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nature genetics, 45, 290-294.
53. Miller, D.R., Leikin, S., Albo, V., Sather, H., Karon, M. & Hammond, D. (1983) Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group. Cancer, 51, 1041-1049.
54. Miller, D.R., Coccia, P.F., Bleyer, W.A., Lukens, J.N., Siegel, S.E., Sather, H.N. & Hammond, G.D. (1989) Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 7, 1807-1815.
55. Mitchell, C., Richards, S., Harrison, C.J. & Eden, T. (2010) Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia, 24, 406-418.
56. Moorman, A.V. (2012) The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood reviews, 26, 123-135.
57. Moorman, A.V., Richards, S.M., Robinson, H.M., Strefford, J.C., Gibson, B.E., Kinsey, S.E., Eden, T.O., Vora, A.J., Mitchell, C.D. & Harrison, C.J. (2007) Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood, 109, 2327-2330.
58. Moorman, A.V., Ensor, H.M., Richards, S.M., Chilton, L., Schwab, C., Kinsey, S.E., Vora, A., Mitchell, C.D. & Harrison, C.J. (2010) Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. The Lancet Oncology, 11, 429-438.
59. Moricke, A., Zimmermann, M., Reiter, A., Henze, G., Schrauder, A., Gadner, H., Ludwig, W.D., Ritter, J., Harbott, J., Mann, G., Klingebiel, T., Zintl, F., Niemeyer, C., Kremens, B., Niggli, F., Niethammer, D., Welte, K., Stanulla, M., Odenwald, E., Riehm, H. & Schrappe, M. (2010) Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia, 24, 265-284.
60. Mullighan, C.G. (2012) Molecular genetics of B-precursor acute lymphoblastic leukemia. The Journal of Clinical Investigation, 122, 3407-3415.
61. Mullighan, C.G., Goorha, S., Radtke, I., Miller, C.B., Coustan-Smith, E., Dalton, J.D., Girtman, K., Mathew, S., Ma, J., Pounds, S.B., Su, X., Pui, C.H., Relling, M.V., Evans, W.E., Shurtleff, S.A. & Downing, J.R. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature, 446, 758-764.
62. Mullighan, C.G., Phillips, L.A., Su, X., Ma, J., Miller, C.B., Shurtleff, S.A. & Downing, J.R. (2008a) Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science, 322, 1377-1380.
63. Mullighan, C.G., Miller, C.B., Radtke, I., Phillips, L.A., Dalton, J., Ma, J., White, D., Hughes, T.P., Le Beau, M.M., Pui, C.H., Relling, M.V., Shurtleff, S.A. & Downing, J.R. (2008b) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature, 453, 110-114.
64. Mullighan, C.G., Su, X., Zhang, J., Radtke, I., Phillips, L.A., Miller, C.B., Ma, J., Liu, W., Cheng, C., Schulman, B.A., Harvey, R.C., Chen, I.M., Clifford, R.J., Carroll, W.L., Reaman, G., Bowman, W.P., Devidas, M., Gerhard, D.S., Yang, W., Relling, M.V., Shurtleff, S.A., Campana, D., Borowitz, M.J., Pui, C.H., Smith, M., Hunger, S.P., Willman, C.L. & Downing, J.R. (2009a) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. The New England Journal of Medicine, 360, 470-480.
65. Mullighan, C.G., Collins-Underwood, J.R., Phillips, L.A., Loudin, M.G., Liu, W., Zhang, J., Ma, J., Coustan-Smith, E., Harvey, R.C., Willman, C.L., Mikhail, F.M., Meyer, J., Carroll, A.J., Williams, R.T., Cheng, J., Heerema, N.A., Basso, G., Pession, A., Pui, C.H., Raimondi, S.C., Hunger, S.P., Downing, J.R., Carroll, W.L. & Rabin, K.R. (2009b) Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nature Genetics, 41, 1243-1246.
66. Mullighan, C.G., Zhang, J., Harvey, R.C., Collins-Underwood, J.R., Schulman, B.A., Phillips, L.A., Tasian, S.K., Loh, M.L., Su, X., Liu, W., Devidas, M., Atlas, S.R., Chen, I.M., Clifford, R.J., Gerhard, D.S., Carroll, W.L., Reaman, G.H., Smith, M., Downing, J.R., Hunger, S.P. & Willman, C.L. (2009c) JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the Unite States of America, 106, 9414-9418.
67. Mullighan, C.G., Zhang, J., Kasper, L.H., Lerach, S., Payne-Turner, D., Phillips, L.A., Heatley, S.L., Holmfeldt, L., Collins-Underwood, J.R., Ma, J., Buetow, K.H., Pui, C.H., Baker, S.D., Brindle, P.K. & Downing, J.R. (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature, 471, 235-239.
68. Nachman, J.B., Sather, H.N., Sensel, M.G., Trigg, M.E., Cherlow, J.M., Lukens, J.N., Wolff, L., Uckun, F.M. & Gaynon, P.S. (1998) Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. The New England Journal of Medicine, 338, 1663-1671.
69. Nachman, J.B., Heerema, N.A., Sather, H., Camitta, B., Forestier, E., Harrison, C.J., Dastugue, N., Schrappe, M., Pui, C.H., Basso, G., Silverman, L.B. & Janka-Schaub, G.E. (2007) Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood, 110, 1112-1115.
70. Neale, G.A., Coustan-Smith, E., Stow, P., Pan, Q., Chen, X., Pui, C.H. & Campana, D. (2004) Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia, 18, 934-938.
71. Nguyen, K., Devidas, M., Cheng, S.C., La, M., Raetz, E.A., Carroll, W.L., Winick, N.J., Hunger, S.P., Gaynon, P.S. & Loh, M.L. (2008) Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia, 22, 2142-2150.
72. Parker, H., An, Q., Barber, K., Case, M., Davies, T., Konn, Z., Stewart, A., Wright, S., Griffiths, M., Ross, F.M., Moorman, A.V., Hall, A.G., Irving, J.A., Harrison, C.J. & Strefford, J.C. (2008) The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. Genes, chromosomes & cancer, 47, 1118-1125.
73. Paulsson, K., Forestier, E., Lilljebjorn, H., Heldrup, J., Behrendtz, M., Young, B.D. & Johansson, B. (2010) Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 107, 21719-21724.
74. Pieters, R., Schrappe, M., De Lorenzo, P., Hann, I., De Rossi, G., Felice, M., Hovi, L., LeBlanc, T., Szczepanski, T., Ferster, A., Janka, G., Rubnitz, J., Silverman, L., Stary, J., Campbell, M., Li, C.K., Mann, G., Suppiah, R., Biondi, A., Vora, A. & Valsecchi, M.G. (2007) A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet, 370, 240-250.
75. Pollock, B.H., DeBaun, M.R., Camitta, B.M., Shuster, J.J., Ravindranath, Y., Pullen, D.J., Land, V.J., Mahoney, D.H. Jr, Lauer, S.J. & Murphy, S.B. (2000) Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 18, 813-823.
76. Pui, C.H. & Thiel, E. (2009) Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Seminars in oncology, 36, S2-S16.
77. Pui, C.H., Pei, D., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Raimondi, S.C., Onciu, M., Campana, D., Kun, L.E., Jeha, S., Cheng, C., Howard, S.C., Metzger, M.L., Bhojwani, D., Downing, J.R., Evans, W.E. & Relling, M.V. (2010) Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia, 24, 371-382.
78. Pui, C.H., Mullighan, C.G., Evans, W.E. & Relling, M.V. (2012) Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood, 120, 1165-1174.
79. Qazi, S. & Uckun, F.M. (2010) Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsets. British journal of haematology, 149, 865-873.
80. Raetz, E.A., Borowitz, M.J., Devidas, M., Linda, S.B., Hunger, S.P., Winick, N.J., Camitta, B.M., Gaynon, P.S. & Carroll, W.L. (2008) Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: a Children's Oncology Group Study[corrected]. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26, 3971-3978.
81. Rand, V., Parker, H., Russell, L.J., Schwab, C., Ensor, H., Irving, J., Jones, L., Masic, D., Minto, L., Morrison, H., Ryan, S., Robinson, H., Sinclair, P., Moorman, A.V., Strefford, J.C. & Harrison, C.J. (2011) Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. Blood, 117, 6848-6855.
82. Rehe, K., Wilson, K., Bomken, S., Williamson, D., Irving, J., den Boer, M.L., Stanulla, M., Schrappe, M., Hall, A.G., Heidenreich, O. & Vormoor, J. (2013) Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations. EMBO Molecular Medicine, 5, 38-51.
83. Relling, M.V., Gardner, E.E., Sandborn, W.J., Schmiegelow, K., Pui, C.H., Yee, S.W., Stein, C.M., Carrillo, M., Evans, W.E. & Klein, T.E. (2011) Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clinical pharmacology and therapeutics, 89, 387-391.
84. Roberts, K.G., Morin, R.D., Zhang, J., Hirst, M., Zhao, Y., Su, X., Chen, S.C., Payne-Turner, D., Churchman, M.L., Harvey, R.C., Chen, X., Kasap, C., Yan, C., Becksfort, J., Finney, R.P., Teachey, D.T., Maude, S.L., Tse, K., Moore, R., Jones, S., Mungall, K., Birol, I., Edmonson, M.N., Hu, Y., Buetow, K.E., Chen, I.M., Carroll, W.L., Wei, L., Ma, J., Kleppe, M., Levine, R.L., Garcia-Manero, G., Larsen, E., Shah, N.P., Devidas, M., Reaman, G., Smith, M., Paugh, S.W., Evans, W.E., Grupp, S.A., Jeha, S., Pui, C.H., Gerhard, D.S., Downing, J.R., Willman, C.L., Loh, M., Hunger, S.P., Marra, M.A. & Mullighan, C.G. (2012) Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell, 22, 153-166.
85. Russell, L.J., Capasso, M., Vater, I., Akasaka, T., Bernard, O.A., Calasanz, M.J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., Guttery, D.S., Haferlach, C., Harder, L., Heidenreich, O., Irving, J., Kearney, L., Nguyen-Khac, F., Machado, L., Minto, L., Majid, A., Moorman, A.V., Morrison, H., Rand, V., Strefford, J.C., Schwab, C., Tonnies, H., Dyer, M.J., Siebert, R. & Harrison, C.J. (2009) Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood, 114, 2688-2698.
86. Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W.D., Henze, G., Gadner, H., Odenwald, E. & Riehm, H. (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia, 14, 2205-2222.
87. Schrappe, M., Valsecchi, M.G., Bartram, C.R., Schrauder, A., Panzer-Grumayer, R., Moricke, A., Parasole, R., Zimmermann, M., Dworzak, M., Buldini, B., Reiter, A., Basso, G., Klingebiel, T., Messina, C., Ratei, R., Cazzaniga, G., Koehler, R., Locatelli, F., Schafer, B.W., Arico, M., Welte, K., van Dongen, J.J., Gadner, H., Biondi, A. & Conter, V. (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118, 2077-2084.
88. Schrappe, M., Hunger, S.P., Pui, C.H., Saha, V., Gaynon, P.S., Baruchel, A., Conter, V., Otten, J., Ohara, A., Versluys, A.B., Escherich, G., Heyman, M., Silverman, L.B., Horibe, K., Mann, G., Camitta, B.M., Harbott, J., Riehm, H., Richards, S., Devidas, M. & Zimmermann, M. (2012) Outcomes after induction failure in childhood acute lymphoblastic leukemia. The New England Journal of Medicine, 366, 1371-1381.
89. Schrijver, I., Aziz, N., Farkas, D.H., Furtado, M., Gonzalez, A.F., Greiner, T.C., Grody, W.W., Hambuch, T., Kalman, L., Kant, J.A., Klein, R.D., Leonard, D.G., Lubin, I.M., Mao, R., Nagan, N., Pratt, V.M., Sobel, M.E., Voelkerding, K.V. & Gibson, J.S. (2012) Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics: JMD, 14, 525-540.
90. Schultz, K.R., Pullen, D.J., Sather, H.N., Shuster, J.J., Devidas, M., Borowitz, M.J., Carroll, A.J., Heerema, N.A., Rubnitz, J.E., Loh, M.L., Raetz, E.A., Winick, N.J., Hunger, S.P., Carroll, W.L., Gaynon, P.S. & Camitta, B.M. (2007) Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood, 109, 926-935.
91. Schultz, K.R., Bowman, W.P., Aledo, A., Slayton, W.B., Sather, H., Devidas, M., Wang, C., Davies, S.M., Gaynon, P.S., Trigg, M., Rutledge, R., Burden, L., Jorstad, D., Carroll, A., Heerema, N.A., Winick, N., Borowitz, M.J., Hunger, S.P., Carroll, W.L. & Camitta, B. (2009) Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27, 5175-5181.
92. Silverman, L.B., Stevenson, K.E., O'Brien, J.E., Asselin, B.L., Barr, R.D., Clavell, L., Cole, P.D., Kelly, K.M., Laverdiere, C., Michon, B., Schorin, M.A., Schwartz, C.L., O'Holleran, E.W., Neuberg, D.S., Cohen, H.J. & Sallan, S.E. (2010) Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia, 24, 320-334.
93. Smith, M., Arthur, D., Camitta, B., Carroll, A.J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E.L., Link, M., Murphy, S., Pui, C.H., Pullen, J., Reamon, G., Sallan, S.E., Sather, H., Shuster, J., Simon, R., Trigg, M., Tubergen, D., Uckun, F. & Ungerleider, R. (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 14, 18-24.
94. Stam, R.W., den Boer, M.L. & Pieters, R. (2006) Towards targeted therapy for infant acute lymphoblastic leukaemia. British journal of haematology, 132, 539-551.
95. Suryanarayan, K., Hunger, S.P., Kohler, S., Carroll, A.J., Crist, W., Link, M.P. & Cleary, M.L. (1991) Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. Blood, 77, 324-330.
96. Sutcliffe, M.J., Shuster, J.J., Sather, H.N., Camitta, B.M., Pullen, J., Schultz, K.R., Borowitz, M.J., Gaynon, P.S., Carroll, A.J. & Heerema, N.A. (2005) High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia, 19, 734-740.
97. Tzoneva, G., Perez-Garcia, A., Carpenter, Z., Khiabanian, H., Tosello, V., Allegretta, M., Paietta, E., Racevskis, J., Rowe, J.M., Tallman, M.S., Paganin, M., Basso, G., Hof, J., Kirschner-Schwabe, R., Palomero, T., Rabadan, R. & Ferrando, A. (2013) Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nature medicine, 19, 368-371.
98. Van der Velden, V.H., Corral, L., Valsecchi, M.G., Jansen, M.W., De Lorenzo, P., Cazzaniga, G., Panzer-Grumayer, E.R., Schrappe, M., Schrauder, A., Meyer, C., Marschalek, R., Nigro, L.L., Metzler, M., Basso, G., Mann, G., Den Boer, M.L., Biondi, A., Pieters, R. & Van Dongen, J.J. (2009) Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia, 23, 1073-1079.
99. Van Vlierberghe, P. & Ferrando, A. (2012) The molecular basis of T cell acute lymphoblastic leukemia. The Journal of Clinical Investigation, 122, 3398-3406.
100. van der Velden, V.H., Jacobs, D.C., Wijkhuijs, A.J., Comans-Bitter, W.M., Willemse, M.J., Hahlen, K., Kamps, W.A., van Wering, E.R. & van Dongen, J.J. (2002) Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. Leukemia, 16, 1432-1436.
101. Viana, M.B., Murao, M., Ramos, G., Oliveira, H.M., de Carvalho, R.I., de Bastos, M., Colosimo, E.A. & Silvestrini, W.S. (1994) Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Archives of disease in childhood, 71, 304-310.
102. Virely, C., Moulin, S., Cobaleda, C., Lasgi, C., Alberdi, A., Soulier, J., Sigaux, F., Chan, S., Kastner, P. & Ghysdael, J. (2010) Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia. Leukemia, 24, 1200-1204.
103. Vora, A., Goulden, N., Wade, R., Mitchell, C., Hancock, J., Hough, R., Rowntree, C. & Richards, S. (2013) Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. The Lancet Oncology, 14, 199-209.
104. Wu, D., Sherwood, A., Fromm, J.R., Winter, S.S., Dunsmore, K.P., Loh, M.L., Greisman, H.A., Sabath, D.E., Wood, B.L. & Robins, H. (2012) High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Science Translational Medicine, 4, 134ra163.
105. Xuan, J., Yu, Y., Qing, T., Guo, L. & Shi, L. (2012) Next-generation sequencing in the clinic: promises and challenges. Cancer letters, doi: 10.1016/j.canlet.2012.11.025.
106. Yang, J.J., Cheng, C., Yang, W., Pei, D., Cao, X., Fan, Y., Pounds, S.B., Neale, G., Trevino, L.R., French, D., Campana, D., Downing, J.R., Evans, W.E., Pui, C.H., Devidas, M., Bowman, W.P., Camitta, B.M., Willman, C.L., Davies, S.M., Borowitz, M.J., Carroll, W.L., Hunger, S.P. & Relling, M.V. (2009) Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA: the journal of the American Medical Association, 301, 393-403.
107. Yang, J.J., Cheng, C., Devidas, M., Cao, X., Fan, Y., Campana, D., Yang, W., Neale, G., Cox, N.J., Scheet, P., Borowitz, M.J., Winick, N.J., Martin, P.L., Willman, C.L., Bowman, W.P., Camitta, B.M., Carroll, A., Reaman, G.H., Carroll, W.L., Loh, M., Hunger, S.P., Pui, C.H., Evans, W.E. & Relling, M.V. (2011) Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nature genetics, 43, 237-241.
108. Yoda, A., Yoda, Y., Chiaretti, S., Bar-Natan, M., Mani, K., Rodig, S.J., West, N., Xiao, Y., Brown, J.R., Mitsiades, C., Sattler, M., Kutok, J.L., DeAngelo, D.J., Wadleigh, M., Piciocchi, A., Dal Cin, P., Bradner, J.E., Griffin, J.D., Anderson, K.C., Stone, R.M., Ritz, J., Foa, R., Aster, J.C., Frank, D.A. & Weinstock, D.M. (2010) Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the Unite States of America, 107, 252-257.
109. Zhang, J., Mullighan, C.G., Harvey, R.C., Wu, G., Chen, X., Edmonson, M., Buetow, K.H., Carroll, W.L., Chen, I.M., Devidas, M., Gerhard, D.S., Loh, M.L., Reaman, G.H., Relling, M.V., Camitta, B.M., Bowman, W.P., Smith, M.A., Willman, C.L., Downing, J.R. & Hunger, S.P. (2011) Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood, 118, 3080-3087.
110. Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S.L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., Lu, C., Chen, S.C., Wei, L., Collins-Underwood, J.R., Ma, J., Roberts, K.G., Pounds, S.B., Ulyanov, A., Becksfort, J., Gupta, P., Huether, R., Kriwacki, R.W., Parker, M., McGoldrick, D.J., Zhao, D., Alford, D., Espy, S., Bobba, K.C., Song, G., Pei, D., Cheng, C., Roberts, S., Barbato, M.I., Campana, D., Coustan-Smith, E., Shurtleff, S.A., Raimondi, S.C., Kleppe, M., Cools, J., Shimano, K.A., Hermiston, M.L., Doulatov, S., Eppert, K., Laurenti, E., Notta, F., Dick, J.E., Basso, G., Hunger, S.P., Loh, M.L., Devidas, M., Wood, B., Winter, S., Dunsmore, K.P., Fulton, R.S., Fulton, L.L., Hong, X., Harris, C.C., Dooling, D.J., Ochoa, K., Johnson, K.J., Obenauer, J.C., Evans, W.E., Pui, C.H., Naeve, C.W., Ley, T.J., Mardis, E.R., Wilson, R.K., Downing, J.R. & Mullighan, C.G. (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature, 481, 157-163.